Peer-reviewed journal articles (260)
  1. 167. Saerens, M., Latinne, P., & Decaestecker, C. (2002). Adjusting the outputs of a classifier to new a priori probabilities: a simple procedure. Neural computation, 14(1), 21-41. doi:10.1162/089976602753284446
  2. 168. Saerens, M., Latinne, P., & Decaestecker, C. (2002). Any reasonable cost function can be used for a posteriori probability approximation. IEEE transactions on neural networks, 13(5), 1204-1210. doi:10.1109/TNN.2002.1031952
  3. 169. Belot, N., Rorive, S., Doyen, I., Lefranc, F., Bruyneel, E., Dedecker, R., Micik, S., Brotchi, J., Decaestecker, C., Salmon, I., Kiss, R., & Camby, I. (2001). Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features. GLIA, 36(3), 375-390. doi:10.1002/glia.1124
  4. 170. Kucharczak, J., Pannequin, J., Camby, I., Decaestecker, C., Kiss, R., & Martinez, J. (2001). Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration. Oncogene, 20(48), 7021-7028. doi:10.1038/sj.onc.1204882
  5. 171. Choufani, G., Ghanooni, R., Decaestecker, C., Delbrouck, C., Simon, P., Schüring, M.-P., Zick, Y., Hassid, S., Gabius, H.-J., & Kiss, R. (2001). Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3. The Laryngoscope, 111(9), 1656-1662. doi:10.1097/00005537-200109000-00031
  6. 172. Delfourne, E., Darro, F., Bontemps-Subielos, N., Decaestecker, C., Bastide, J., Frydman, A., & Kiss, R. (2001). Synthesis and characterization of the antitumor activities of analogues of meridine, a marine pyridoacridine alkaloid. Journal of medicinal chemistry, 44(20), 3275-3282. doi:10.1021/jm0108496
  7. 173. Bronckart, Y., Decaestecker, C., Nagy, N., Harper, L. H., Schäfer, B. W., Salmon, I., Pochet, R., Kiss, R., & Heizmann, C. W. (2001). Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins. Histology and histopathology, 16(3), 707-712.
  8. 174. Danguy, A., Rorive, S., Decaestecker, C., Bronckart, Y., Kaltner, H., Hadari, Y. R., Goren, R., Zich, Y., Petein, M., Salmon, I., Gabius, H.-J., & Kiss, R. (2001). Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histology and histopathology, 16(3), 861-868.
  9. 175. Berthe, J.-V., Remmelink, M., Werry, J., Salmon, I., Kiss, R., & Decaestecker, C. (2001). The contribution of image cytometry to the characterization of clinical subgroups of lipomas. International journal of oncology, 18(6), 1315-1321.
  10. 176. Sheikholeslam-zadeh, R., Decaestecker, C., Delbrouck, C., Danguy, A., Salmon, I., Zick, Y., Kaltner, H., Hassid, S., Gabius, H.-J., Kiss, R., & Choufani, G. (2001). The levels of expression of galectin-3, but not of galectin-1 and galectin-8, correlate with apoptosis in human cholesteatomas. The Laryngoscope, 111(6), 1042-1047. doi:10.1097/00005537-200106000-00020
  11. 177. Simon, P., Decaestecker, C., Choufani, G., Delbrouck, C., Danguy, A., Salmon, I., Zick, Y., Kaltner, H., Hassid, S., Gabius, H.-J., Kiss, R., & Darro, F. (2001). The levels of retinoid RARβ receptors correlate with galectin-1, -3 and -8 expression in human cholesteatomas. Hearing research, 156(1-2), 1-9. doi:10.1016/S0378-5955(01)00230-1
  12. 178. Nagy, N., Brenner, C., Markadieu, N., Chaboteaux, C., Camby, I., Schäfer, B. W., Pochet, R., Heizmann, C. W., Salmon, I., Kiss, R., & Decaestecker, C. (2001). S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration. Laboratory investigation, 81(4), 599-612.
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Next >>